Request for Nominations to the Advisory Council on Alzheimer's Research, Care, and Services, 23730 [2021-09363]

Download as PDF 23730 Federal Register / Vol. 86, No. 84 / Tuesday, May 4, 2021 / Notices CMS–10215 Identifying Medicaid Payment for Physician Administered Drugs DEPARTMENT OF HEALTH AND HUMAN SERVICES Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collection khammond on DSKJM1Z7X2PROD with NOTICES 1. Type of Information Collection Request: Extension of currently approved collection; Title of Information Collection: Identifying Medicaid Payment for Physician Administered Drugs; Use: States are required to provide for the collection and submission of utilization data for certain physician-administered drugs in order to receive federal financial participation for these drugs. Physicians, serving as respondents to states, submit National Drug Code numbers and utilization information for ‘‘J’’ code physician-administered drugs so that the states will have sufficient information to collect drug rebate dollars. Form Number: CMS–10215 (OMB control number: 0938–1026); Frequency: Weekly; Affected Public: Business or other for-profits and Notfor-profit institutions); Number of Respondents: 20,000; Total Annual Responses: 4,589,433; Total Annual Hours: 351,046. (For policy questions regarding this collection contact Michael Forman at 410–786–2666.) Dated: April 29, 2021, William N. Parham, III Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2021–09360 Filed 5–3–21; 8:45 am] BILLING CODE 4120–01–P VerDate Sep<11>2014 17:13 May 03, 2021 Jkt 253001 Request for Nominations to the Advisory Council on Alzheimer’s Research, Care, and Services Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. ACTION: Notice. AGENCY: The Secretary of HHS established the Advisory Council on Alzheimer’s Research, Care, and Services to provide advice and consultation to the Secretary on how to prevent or reduce the burden of Alzheimer’s disease and related dementias on people with the disease and their caregivers. The Secretary signed the charter establishing the Advisory Council on May 23, 2011. HHS is soliciting nominations for seven (7) new non-federal members of the Advisory Council to replace the seven (7) members whose terms will end September 30, 2021. Nominations should include, at a minimum, the nominee’s contact information (current mailing address, email address, and telephone number) and current curriculum vitae or resume. DATES: Submit nominations by email or USPS mail before COB on May 31, 2021. ADDRESSES: Nominations should be sent by email to: Helen Lamont, Ph.D., HHS Office of the Assistant Secretary for Planning and Evaluation, Room 424E, Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201, helen.lamont@hhs.gov and napa@ hhs.gov. SUMMARY: FOR FURTHER INFORMATION CONTACT: Helen Lamont (202) 260–6075, helen.lamont@hhs.gov. SUPPLEMENTARY INFORMATION: The Advisory Council on Alzheimer’s Research, Care, and Services meets quarterly to discuss programs that impact people with Alzheimer’s disease and related dementias and their caregivers. The Advisory Council makes recommendations to Congress and the Secretary of Health and Human Services about ways to reduce the financial impact of Alzheimer’s disease and related dementias and to improve the health outcomes of people with these conditions. The Advisory Council also provides feedback on a National Plan to Address Alzheimer’s disease. On an annual basis, the Advisory Council evaluates the implementation of the recommendations through an updated National Plan. The National Alzheimer’s Project Act, Public Law 111–375 (42 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 U.S.C. 11225), requires that the Secretary of Health and Human Services (HHS) establish the Advisory Council on Alzheimer’s Research, Care, and Services. The Advisory Council is governed by provisions of Public Law 92–463 (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. The Advisory Council consists of 22 members. Ten members are designees from Federal agencies including the Centers for Disease Control and Prevention, Administration for Community Living, Centers for Medicare and Medicaid Services, Indian Health Service, National Institutes of Health, National Science Foundation, Department of Veterans Affairs, Food and Drug Administration, Agency for Healthcare Research and Quality, and the Health Resources and Services Administration. The Advisory Council also consists of 12 non-federal members selected by the Secretary who represent 6 categories of people impacted by dementia: dementia caregivers (2), health care providers (2), representatives of State health departments (2), researchers with dementia-related expertise in basic, translational, clinical, or drug development science (2), voluntary health association representatives (2), and dementia patient advocates, including an advocate who is currently living with dementia (2). At this time, the Secretary shall appoint one caregiver, one healthcare provider, one representative of a State health department, one researcher, one voluntary health association representative, one dementia patient advocate, and one advocate who is a person living with dementia. These new members will replace the seven members whose terms will end on September 30, 2021. After receiving nominations, the Secretary, with input from his staff, will make the final decision, and the new members will be announced soon after. Members shall be invited to serve 4-year terms. The member living with dementia will serve a 2-year term. A member may serve after the expiration of the member’s term until a successor has taken office. Members will serve as Special Government Employees. Dated: April 30, 2021. Rebecca Haffajee, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2021–09363 Filed 5–3–21; 8:45 am] BILLING CODE 4150–05–P E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 86, Number 84 (Tuesday, May 4, 2021)]
[Notices]
[Page 23730]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09363]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Request for Nominations to the Advisory Council on Alzheimer's 
Research, Care, and Services

AGENCY: Office of the Assistant Secretary for Planning and Evaluation, 
Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Secretary of HHS established the Advisory Council on 
Alzheimer's Research, Care, and Services to provide advice and 
consultation to the Secretary on how to prevent or reduce the burden of 
Alzheimer's disease and related dementias on people with the disease 
and their caregivers. The Secretary signed the charter establishing the 
Advisory Council on May 23, 2011. HHS is soliciting nominations for 
seven (7) new non-federal members of the Advisory Council to replace 
the seven (7) members whose terms will end September 30, 2021. 
Nominations should include, at a minimum, the nominee's contact 
information (current mailing address, email address, and telephone 
number) and current curriculum vitae or resume.

DATES: Submit nominations by email or USPS mail before COB on May 31, 
2021.

ADDRESSES: Nominations should be sent by email to: Helen Lamont, Ph.D., 
HHS Office of the Assistant Secretary for Planning and Evaluation, Room 
424E, Humphrey Building, 200 Independence Avenue SW, Washington, DC 
20201, [email protected] and [email protected].

FOR FURTHER INFORMATION CONTACT: Helen Lamont (202) 260-6075, 
[email protected].

SUPPLEMENTARY INFORMATION: The Advisory Council on Alzheimer's 
Research, Care, and Services meets quarterly to discuss programs that 
impact people with Alzheimer's disease and related dementias and their 
caregivers. The Advisory Council makes recommendations to Congress and 
the Secretary of Health and Human Services about ways to reduce the 
financial impact of Alzheimer's disease and related dementias and to 
improve the health outcomes of people with these conditions. The 
Advisory Council also provides feedback on a National Plan to Address 
Alzheimer's disease. On an annual basis, the Advisory Council evaluates 
the implementation of the recommendations through an updated National 
Plan. The National Alzheimer's Project Act, Public Law 111-375 (42 
U.S.C. 11225), requires that the Secretary of Health and Human Services 
(HHS) establish the Advisory Council on Alzheimer's Research, Care, and 
Services. The Advisory Council is governed by provisions of Public Law 
92-463 (5 U.S.C. Appendix 2), which sets forth standards for the 
formation and use of advisory committees.
    The Advisory Council consists of 22 members. Ten members are 
designees from Federal agencies including the Centers for Disease 
Control and Prevention, Administration for Community Living, Centers 
for Medicare and Medicaid Services, Indian Health Service, National 
Institutes of Health, National Science Foundation, Department of 
Veterans Affairs, Food and Drug Administration, Agency for Healthcare 
Research and Quality, and the Health Resources and Services 
Administration. The Advisory Council also consists of 12 non-federal 
members selected by the Secretary who represent 6 categories of people 
impacted by dementia: dementia caregivers (2), health care providers 
(2), representatives of State health departments (2), researchers with 
dementia-related expertise in basic, translational, clinical, or drug 
development science (2), voluntary health association representatives 
(2), and dementia patient advocates, including an advocate who is 
currently living with dementia (2). At this time, the Secretary shall 
appoint one caregiver, one healthcare provider, one representative of a 
State health department, one researcher, one voluntary health 
association representative, one dementia patient advocate, and one 
advocate who is a person living with dementia. These new members will 
replace the seven members whose terms will end on September 30, 2021. 
After receiving nominations, the Secretary, with input from his staff, 
will make the final decision, and the new members will be announced 
soon after. Members shall be invited to serve 4-year terms. The member 
living with dementia will serve a 2-year term. A member may serve after 
the expiration of the member's term until a successor has taken office. 
Members will serve as Special Government Employees.

    Dated: April 30, 2021.
Rebecca Haffajee,
Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2021-09363 Filed 5-3-21; 8:45 am]
BILLING CODE 4150-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.